New Delhi, Dec. 10 -- French pharmaceutical group Servier is sharpening its India strategy with a string of new oncology launches focused on rare cancers, plans for local manufacturing of active ingre... Read More
New Delhi, Dec. 6 -- Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the rema... Read More
Mumbai, Dec. 6 -- On 2 December, the Delhi high court allowed domestic drugmaker Dr Reddy's Laboratories Ltd to manufacture the blockbuster weight-loss injection semaglutide, for which global pharma g... Read More
New Delhi, Dec. 4 -- General Atlantic and Kedaara Capital-backed eyecare chain ASG Eye Hospital plans to invest Rs.1,500-2,000 crore by 2030 to expand its footprint in small cities, signalling growing... Read More
MUMBAI, Dec. 1 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are raising their ambitions, with several now investing heavily in R&D to win con... Read More
MUMBAI, Nov. 29 -- Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are stepping up their ambitions. Several are now pouring capital into research a... Read More
Mumbai, Nov. 20 -- India's national capital has seen two citizen-led protests in November over the government's inaction to address dangerously worsening air quality. Health experts have declared the... Read More
New Delhi, Nov. 18 -- Healthcare startup Qure.ai is betting on partnerships with central and state governments as it seeks to scale its artificial intelligence-led diagnostic tools, particularly for d... Read More
New Delhi, Nov. 13 -- Backed by strong demand across its drug-device and biologics businesses, OneSource Speciality Pharma has raised its FY28 revenue guidance from $400 million to over $500 million, ... Read More
Mumbai, Nov. 12 -- Weight-loss and diabetes drugs such as semaglutide and liraglutide are expected to drive near-term growth in Biocon Ltd's generics business, chief executive and managing director Si... Read More